The discovery of a previously unknown molecular target has inspired what may become a therapeutic breakthrough for people with glioblastoma, the most common and aggressive brain cancer. When people hear the word "cancer" they often picture a single mass, but glioblastoma cells are also highly invasive and spread quickly from the central mass, making it very difficult to fully eradicate. Even with current treatments such as temozolomide, the standard chemotherapy approved to treat glioblastoma, temozolomide-resistant tumours recur in more than 50 per cent of patients with less than one per cent surviving ten years after diagnosis.

https://www.miragenews.com/protein-protein-interaction-discovery-boosts-1081793/

#miragenews